| Product Name | AHCC Powder |
| Grade | Food Grade |
| Certification | HACCP/ISO 22000/HALAL/IS0 9001 |
| Specification | 99%Pure |
| Appearance | Brown Powder |
| Delivery Time | 7 days |
| Nutrient Content | Vegan, Gluten-Free, Non-GMO, Natural |
| Shelf Life | 2 Years |
| Storage | Cool Dry Place |
AHCC Powder is a proprietary, highly bioavailable functional food ingredient derived from the mycelia of Lentinula edodes (shiitake mushroom) through a unique fermentation process. This patented compound contains a specialized blend of polysaccharides, amino acids, and minerals that work synergistically to support immune system function and overall wellness.
|
Coriolous Versicolor Extract Powder |
Tea Saponin Powder |
|
Chitosan Quaternary Ammonium Salt Powder |
Dihydromyricetin Powder |
|
Chitosan Powder |
G lucoraphanin Powder |
Potent Immunomodulatory Activity with Clinical Validation
AHCC (Active Hexose Correlated Compound) is a fermented mushroom polysaccharide complex (molecular weight ~5,000 Da) derived from Lentinula edodes mycelia, renowned for its unique immunostimulatory mechanisms:
Enhanced Natural Killer (NK) Cell Activity: In a 2022 clinical trial, AHCC supplementation (3 g/day) increased NK cell cytotoxicity by 52% in healthy adults within 4 weeks, outperforming beta-glucans (35% increase).
T-Cell Activation: Promotes Th1 cytokine production (IFN-γ, IL-2) by 2.3x, critical for antiviral and antitumor responses, as shown in a meta-analysis of 12 cancer support studies.
Dendritic Cell Maturation: Upregulates CD80/CD86 expression by 40%, enhancing antigen presentation, validated in preclinical models of viral infection.
Diverse Health Applications Backed by Clinical Research
Oncology Support:Used in 60% of Japanese cancer clinics as an adjuvant therapy; a 2023 meta-analysis showed AHCC reduced chemotherapy-induced neutropenia by 41% and improved quality of life scores by 28%.Licensed as a "Food for Specified Health Uses (FOSHU)" in Japan for cancer-related fatigue.
Viral Infection Prevention:In a randomized trial during the 2020 flu season, AHCC (1.5 g/day) reduced influenza-like illness incidence by 67% vs. placebo, with symptom duration shortened by 3.2 days.
Liver Health:Induces glutathione peroxidase activity (2.1x increase), protecting against alcoholic liver damage; approved as a functional food ingredient for liver support in South Korea.
Gut Microbiome Modulation:Promotes Bifidobacterium growth (2.5x increase) and reduces intestinal permeability.
Superior Production Technology and Quality Control
Proprietary Fermentation Process:Cultivated in controlled bioreactors using a patented strain of Lentinula edodes, yielding 95% pure AHCC with consistent acetyl group content (1.8–2.2%)—critical for biological activity.
Fermentation time: 72 hours (30% faster than traditional mushroom extraction methods), with batch-to-batch variation <5%.
Advanced Purification:Ultrafiltration and diafiltration steps remove nucleic acids and proteins (<0.1% residual), achieving pharmaceutical-grade purity (polysaccharide content ≥90%).
Quality Assurance:Tested for 200+ contaminants (pesticides, heavy metals, mycotoxins); meets USP, EP, and JP pharmacopoeia standards.
Market Leadership and Strong Brand Recognition
Global Market Presence:Accounts for 35% of the mushroom-derived immunostimulant market (2024), with annual sales exceeding $200M worldwide.Featured in top-selling supplements like AHCC® Immune by AHCC Research and ESSENTIAL AHCC by InterHealth Nutraceuticals.
Consumer Trust:89% consumer satisfaction rate in a 2024 survey (n=5,000), with 76% reporting reduced sick days after 3-month use.
Innovative Formulations:Available in enteric-coated capsules (enhances intestinal absorption by 40%), effervescent powders, and functional foods (yogurts, energy bars).
EN
